REVERSAL OF MULTI-DRUG RESISTANCE IN MDR CANCER CELL BY 3113, A NEW DIPEPTIDOMIMETIC OF P-AMINOBENZOIC ACID

In this study, we reported for the first time that a new compound named 3113, which is the dipeptidomimetic of p-aminobenzoic acid showed multi-drug resistance (MDR) reversal activity. In MDR cancer cells,..